Catheterization and Cardiovascular Interventions · 2019 · 19 citations · 21 references
MedicineCardiologyInternal MedicineClinical CardiologyHemodynamic ManagementInterventional CardiologyAcute Coronary Syndrome InterventionAcute Coronary SyndromesCardiogenic ShockIschemic Heart DiseaseMyocardial Infarction ComplicationsPercutaneous Coronary InterventionAcute Coronary Syndrome ManagementClinical Outcomes After Percutaneous Coronary InterventionPercutaneous Coronary Intervention CareVentricular Assist Device Support
BACKGROUND: The utilization of mechanical circulatory support (MCS) for percutaneous coronary intervention (PCI) using percutaneous ventricular assist device (PVAD) or intra-aortic balloon pump (IABP) has been increasing. We sought to evaluate the outcome of coronary intervention using PVAD compared with IABP in noncardiogenic shock and nonacute myocardial infarction patients. METHOD: Using the National Inpatient Sampling (NIS) database from 2005 to 2014, we identified patients who underwent PCI using ICD 9 codes. Patients with cardiogenic shock, acute coronary syndrome, or acute myocardial infarction were excluded. Patient was stratified based on the MCS used, either to PVAD or IABP. Univariate and multivariate logistic regression were performed to study PCI outcome using PVAD compared with IABP. RESULTS: Out of 21,848 patients who underwent PCI requiring MCS, 17,270 (79.0%) patients received IABP and 4,578 (21%) patients received PVAD. PVAD patients were older (69 vs. 67, p < .001), were less likely to be women (23.3% vs. 33.3%, p < .001), and had higher rates of hypertension, diabetes, hyperlipidemia prior PCI, prior coronary artery bypass graft surgery, anemia, chronic lung disease, liver disease, renal failure, and peripheral vascular disease compared with IABP group (p ≤ .007). Using Multivariate logistic regression, PVAD patients had lower in-hospital mortality (6.1% vs. 8.8%, adjusted odds ratio [aOR] 0.62; 95% CI 0.51, 0.77, p < .001), vascular complications (4.3% vs. 7.5%, aOR 0.78; 95% CI 0.62, 0.99, p = .046), cardiac complications (5.6% vs. 14.5%, aOR 0.29; 95% CI 0.24, 0.36, p < .001), and respiratory complications (3.8% vs. 9.8%, aOR 0.37; 95% CI 0.28, 0.48, p < .001) compared with patients who received IABP. CONCLUSION: Despite higher comorbidities, nonemergent PCI procedures using PVAD were associated with lower mortality compared with IABP.
21
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Circulation · 2011 · 3.3K citations · Full text
Medicine, Cardiology, Surgery +14
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Sidney C. Smith, Ted Feldman, John W. Hirshfeld et al. · Circulation · 2006 · 2.2K citations
Medicine, Cardiology, Surgery +13
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Journal of the American College of Cardiology · 2011 · 2.2K citations
Medicine, Cardiology, Surgery +14
William W. O’Neill, Neal S. Kleiman, Jeffrey W. Moses et al. · Circulation · 2012 · 851 citations · Full text
Medicine, Cardiology, Surgery +16
Charanjit S. Rihal, Srihari S. Naidu, Michael M. Givertz et al. · Journal of the American College of Cardiology · 2015 · 671 citations
Medicine, Cardiology, Surgery +8